Does chemotherapy reactivate SARS-CoV-2 in cancer patients recovered from prior COVID-19 infection?

Eur Respir J. 2020 Oct 22;56(4):2002672. doi: 10.1183/13993003.02672-2020. Print 2020 Oct.

Jianping Bi^{1

2}, Hong Ma^{3

2}, Dongsheng Zhang^{4

2}, Jing Huang³, Dongqin Yang⁵, Yajie Wang⁶, Vivek Verma¹, Tao Zhang³, Desheng Hu¹, Qi Mei^{7

8}, Guang Han^{1

8}, Jian Li⁹

¹ Dept of Radiation Oncology, Hubei Cancer Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
² Jianping Bi, Hong Ma and Dongsheng Zhang contributed equally as first authors.
³ Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
⁴ Dept of Oncology, Hubei University of Medicine, Suizhou Hospital, Suizhou, China.
⁵ Dept of Oncology, The Fifth Hospital of Wuhan, Wuhan, China.
⁶ Dept of General Surgery, People's Hospital of Dongxihu District, Wuhan, China.
⁷ Dept of Oncology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
⁸ Guang Han and Qi Mei contributed equally to this article as lead authors and supervised the work.
⁹ Institute of Medical Information, Biometry, and Epidemiology, Ludwig-Maximilian-University Munich, Munich, Germany.

Abstract

Recovered COVID-19 cancer patients remain negative for SARS-CoV-2 after delivery of chemotherapy https://bit.ly/2QNTqO0